South Plains Financial, Inc. Announces Third Quarter 2024 Earnings Call
LUBBOCK, Texas, Oct. 09, 2024 (GLOBE NEWSWIRE) — South Plains Financial, Inc. (NASDAQ:SPFI) (“South Plains” or the “Company”), the parent […]
APA Corporation Provides Third-Quarter 2024 Supplemental Information and Schedules Results Conference Call for November 7 at 10 a.m. Central Time
HOUSTON, Oct. 09, 2024 (GLOBE NEWSWIRE) — APA Corporation (Nasdaq: APA) today provided supplemental information regarding certain third-quarter 2024 financial […]
Urgently Earns AutoTech Breakthrough Award for ‘Overall Transportation Tech of the Year’
VIENNA, Va., Oct. 09, 2024 (GLOBE NEWSWIRE) — Urgent.ly, Inc. (Nasdaq: ULY) (“Urgently”), a U.S.-based leading provider of digital roadside […]
Latham Group Appoints New Independent Director
LATHAM, N.Y., Oct. 09, 2024 (GLOBE NEWSWIRE) — Latham Group, Inc., (NASDAQ:SWIM), the largest designer, manufacturer, and marketer of in-ground […]
LPL Financial Announces Third Quarter 2024 Earnings Release Date and Conference Call
SAN DIEGO, Oct. 09, 2024 (GLOBE NEWSWIRE) — LPL Financial Holdings Inc. (Nasdaq: LPLA) (the “Company”), the parent corporation of […]
Applied Digital Reports Fiscal First Quarter 2025 Results
DALLAS, Oct. 09, 2024 (GLOBE NEWSWIRE) — Applied Digital Corporation (Nasdaq: APLD) (“Applied Digital” or the “Company”), a designer, builder, […]
Encore Capital Group to Announce Third Quarter 2024 Financial Results on November 6
SAN DIEGO, Oct. 09, 2024 (GLOBE NEWSWIRE) — Encore Capital Group, Inc. (Nasdaq:ECPG), an international specialty finance company, announced today […]
Appian To Announce Third Quarter 2024 Financial Results on November 7, 2024
MCLEAN, Va., Oct. 09, 2024 (GLOBE NEWSWIRE) — Appian (Nasdaq: APPN) today announced that it will release financial results for […]
Adaptive Biotechnologies to Report Third Quarter 2024 Financial Results on November 7, 2024
SEATTLE, Oct. 09, 2024 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to […]
Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
BEDFORD, Mass., Oct. 09, 2024 (GLOBE NEWSWIRE) — Ocular Therapeutix, Inc. (NASDAQ:OCUL, “Ocular”), a biopharmaceutical company committed to improving vision […]
